Therefore, the meaning of this protein is enhanced by the fact that a glycated form of apolipoprotein A-IV has been demonstrated to induce atherogenesis in patients affected by T2DM and with CHD [29]. This evidence concerns the gene APOA4 and coronary artery disorder.